Literature DB >> 28923759

Extending the Reach of Evidence-Based Medicine: A Proposed Categorization of Lower-Level Evidence.

Frank C Detterbeck1, Michael K Gould2, Sandra Zelman Lewis3, Sheena Patel4.   

Abstract

Clinical practice involves making many treatment decisions for which only limited formal evidence exists. While the methodology of evidence-based medicine (EBM) has evolved tremendously, there is a need to better characterize lower-level evidence. This should enhance the ability to appropriately weigh the evidence against other considerations, and counter the temptation to think it is more robust than it actually is. A framework to categorize lower-level evidence is proposed, consisting of nonrandomized comparisons, extrapolation using indirect evidence, rationale, and clinical experience (ie, an accumulated general impression). Subtypes are recognized within these categories, based on the degree of confounding in nonrandomized comparisons, the uncertainty involved in extrapolation from indirect evidence, and the plausibility of a rationale. Categorizing the available evidence in this way can promote a better understanding of the strengths and limitations of using such evidence as the basis for treatment decisions in clinically relevant areas that are devoid of higher-level evidence.
Copyright © 2017 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Keywords:  GRADE; evidence-based medicine; lower-level evidence

Mesh:

Year:  2017        PMID: 28923759     DOI: 10.1016/j.chest.2017.09.006

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

Review 1.  A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 1: a guide to decision-making.

Authors:  Frank C Detterbeck; Justin D Blasberg; Gavitt A Woodard; Roy H Decker; Ulas Kumbasar; Henry S Park; Vincent J Mase; Brett C Bade; Andrew X Li; Whitney S Brandt; David C Madoff
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

2.  Oncologic outcomes of lobectomy vs. segmentectomy in non-small cell lung cancer with clinical T1N0M0 stage: a literature review and meta-analysis.

Authors:  Yu-Zhen Zheng; Wen-Yu Zhai; Jian Zhao; Rui-Xing Luo; Wan-Jie Gu; Shen-Shen Fu; Da Wu; Lian-Xiong Yuan; Wei Jiang; Yasuhiro Tsutani; Hong-Ying Liao; Xiao-Qiang Li
Journal:  J Thorac Dis       Date:  2020-06       Impact factor: 2.895

Review 3.  A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors.

Authors:  Brett C Bade; Justin D Blasberg; Vincent J Mase; Ulas Kumbasar; Andrew X Li; Henry S Park; Roy H Decker; David C Madoff; Whitney S Brandt; Gavitt A Woodard; Frank C Detterbeck
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.